Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Ambulatory Oxygen Therapy for Individuals With Mild-to-moderate Interstitial Lung Disease

NCT06053164 is registered in ClinicalTrials.gov with University of Alberta as lead sponsor.

NCT NCT06053164
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06053164 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Ambulatory Oxygen Therapy for Individuals With Mild-to-moderate Interstitial Lung Disease
Lead sponsor
University of Alberta
Phase
Phase 2
Overall status
Recruiting
Start date
July 1, 2025
Completion date
September 1, 2026
Enrollment
60 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

fibrotic interstitial lung disease